An school-age child who uses a SABA and an inhaled corticosteroid medication is seen in the clinic for an acute asthma exacerbation. After 4 puffs of an inhaled short-acting B2-agonist (SABA) every 20 minutes for three treatments, spirometry testing shows an FEV1 of 60% of the child's personal best. What will the primary care pediatric nurse practitioner do next?

An school-age child who uses a SABA and an inhaled corticosteroid medication is seen in the clinic for an acute asthma exacerbation. After 4 puffs of an inhaled short-acting B2-agonist (SABA) every 20 minutes for three treatments, spirometry testing shows an FEV1 of 60% of the child's personal best. What will the primary care pediatric nurse practitioner do next?

• A. Administer an oral corticosteroid and repeat the three treatments of the inhaled SABA.
• B. Admit the child to the hospital for every 2 hour inhaled SABA and intravenous steroids.
• C. Give the child 2 mg/kg of an oral corticosteroid and have the child taken to the emergency department.
• D. Order an oral corticosteroid, continue the SABA every 3 to 4 hours, and follow closely.

Answer: (D)

The main approach in an acute asthma flare is to keep reversing bronchoconstriction with bronchodilators and to treat the underlying airway inflammation with systemic steroids when the response to bronchodilation is incomplete. After giving repeated SABA treatments, an FEV1 at 60% of the child’s personal best shows persistent, moderate obstruction but the child remains stable enough to avoid immediate hospitalization. In this situation, the best plan is to start an oral corticosteroid to reduce airway inflammation and continue bronchodilator therapy at regular intervals (every 3–4 hours) with close follow-up. Systemic steroids help shorten the duration and severity of the flare by dampening the inflammatory response in the airways, which SABA alone cannot do. Continuing the SABA every few hours ensures ongoing bronchodilation and guards against renewed bronchoconstriction as the inflammation is being treated. Close follow-up is crucial to ensure the child improves and to decide if further escalation is needed. Hospital admission or IV steroids is reserved for signs of severe distress, poor response to initial therapy, hypoxemia, or fatigue, which aren’t present here. Repeating only more SABA without addressing inflammation would be insufficient, and sending the child to the emergency department or hospital would be unnecessary given the current stability with a plan for outpatient management and monitoring.

The main approach in an acute asthma flare is to keep reversing bronchoconstriction with bronchodilators and to treat the underlying airway inflammation with systemic steroids when the response to bronchodilation is incomplete. After giving repeated SABA treatments, an FEV1 at 60% of the child’s personal best shows persistent, moderate obstruction but the child remains stable enough to avoid immediate hospitalization. In this situation, the best plan is to start an oral corticosteroid to reduce airway inflammation and continue bronchodilator therapy at regular intervals (every 3–4 hours) with close follow-up.

Systemic steroids help shorten the duration and severity of the flare by dampening the inflammatory response in the airways, which SABA alone cannot do. Continuing the SABA every few hours ensures ongoing bronchodilation and guards against renewed bronchoconstriction as the inflammation is being treated. Close follow-up is crucial to ensure the child improves and to decide if further escalation is needed.

Hospital admission or IV steroids is reserved for signs of severe distress, poor response to initial therapy, hypoxemia, or fatigue, which aren’t present here. Repeating only more SABA without addressing inflammation would be insufficient, and sending the child to the emergency department or hospital would be unnecessary given the current stability with a plan for outpatient management and monitoring.